Learn More
Medchemexpress LLC CDK12-IN-E9 5mg | 2020052-55-3 | 434.53 | C24H30N6O2 | 5 MG

Supplier: Medchemexpress LLC HY117203A5MG
CDK12-IN-E9 is a research-stage kinase inhibitor used to probe CDK12-mediated transcriptional regulation, DNA damage response, and cell-cycle processes. It is supplied as a high-purity solid and as a 10 mM solution in DMSO, and is intended for laboratory research use only.
- Potent, selective covalent CDK12 inhibition.
- Non-covalent inhibitory activity against CDK9.
- High reported purity (99.71%).
- Available as solid and DMSO solution formats.
- Suitable for biochemical and cell-based research applications.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.